Biotech Values

[Biowatch]

Impressive that generics article was front page news in the Washington Post.

DC is a political town, with budget concerns and Federal regulations and agencies always at the top of the news.

The rising cost of healthcare is a hot topic these days.

I don't understand why they don't add more staff to the generics division at the FDA, but their hands may be tied.